Efficacy and Safety of Bempedoic Acid for Hypercholesterolemia in Japan: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Trial
The efficacy and safety of bempedoic acid in Japanese patients with elevated LDL-C levels were confirmed. The 180 mg dosage of bempedoic acid was found to be appropriate for a Japanese phase 3 trial.
Authors
- Hitomi Fujita (ORCID: https://orcid.org/0000-0003-2859-3381)
- Ryuki Kitamoto
- Daisuke Yokota
- Shizuya Yamashita (ORCID: https://orcid.org/0000-0001-6645-4185)
- Yuki Morikawa-Isogai
Institutions
- Otsuka (Japan) (JP)
- Otsuka Pharmaceutical (Spain) (ES)
Publication Details
- Journal
- Journal of Atherosclerosis and Thrombosis
- Published
- 2025-02-28
- DOI
- https://doi.org/10.5551/jat.65336
- Citations
- 3
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Otsuka Pharmaceutical